Enarodustat ( JTZ-951 ) is an orally-active HIF-PH inhibitor with an EC50 of 0.22 Μm, that promotes erythropoiesis by accelerating the endogenous production of erythropoietin (EPO) and controlling the expression of molecules responsible for iron metabolism. The Phase 3 clinical studies confirmed efficacy in anemic patients with non-dialysis dependent CKD and dialysis dependent CKD. Furthermore, the favorable tolerability profile on safety of enarodustat was obtained during the studies
仅供研究使用。 我们不向患者出售。
名称 | Enarodustat ( JTZ-951 ) |
---|---|
Iupac 化学名称 | N-[7-hydroxy-5-(2-phenylethyl)[1,2,4]triazolo[1,5-a]pyridine-8-carbonyl]glycine |
同义词 | Enarodustat ; JTZ-951 ; JTZ 951 ; JTZ951 ; |
英文同义词 | Enarodustat ; JTZ-951 ; JTZ 951 ; JTZ951 ; |
分子式 | C17H16N4O4 |
分子量 | 340.33 |
Smile | O=C(O)CNC(C1=C(O)C=C(CCC2=CC=CC=C2)N3C1=NC=N3)=O |
InChiKey | NALAUGMPMIVAOW-UHFFFAOYSA-N |
InChi | InChI=1S/C17H16N4O4/c22-13-8-12(7-6-11-4-2-1-3-5-11)21-16(19-10-20-21)15(13)17(25)18-9-14(23)24/h1-5,8,10,22H,6-7,9H2,(H,18,25)(H,23,24) |
Cas号 | 1262132-81-9 |
相关CAS号 | 1262132-81-9 |
包装 | 价格 | 库存 | 纯度 | 备货期 |
---|---|---|---|---|
大货 | 询价 | 询价 | 询价 |
外观性状 | 类白色固体 |
---|---|
纯度 | 98% Min. |
存储 | 短期可在0-4度保存,数天至数月;长期可在-20度保存三年。 |
可溶性 | 可溶于DMSO;不溶于水 |
处理方式 | Avoid inhalation, contact with eyes and skin. Avoid dust and aerosol formation. Use only in areas with appropriate exhaust ventilation. |
运输条件 | 作为非危险化学品在环境温度下装运。这种产品在正常运输和海关工作期间可以稳定几周 |
海关编码 | 2933599090 |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |